全文获取类型
收费全文 | 707021篇 |
免费 | 48974篇 |
国内免费 | 1304篇 |
专业分类
耳鼻咽喉 | 9169篇 |
儿科学 | 23284篇 |
妇产科学 | 17618篇 |
基础医学 | 110516篇 |
口腔科学 | 20043篇 |
临床医学 | 63928篇 |
内科学 | 134525篇 |
皮肤病学 | 16163篇 |
神经病学 | 49528篇 |
特种医学 | 25770篇 |
外国民族医学 | 76篇 |
外科学 | 104598篇 |
综合类 | 14878篇 |
现状与发展 | 2篇 |
一般理论 | 160篇 |
预防医学 | 51589篇 |
眼科学 | 16329篇 |
药学 | 54053篇 |
3篇 | |
中国医学 | 2361篇 |
肿瘤学 | 42706篇 |
出版年
2019年 | 5453篇 |
2018年 | 7891篇 |
2017年 | 6117篇 |
2016年 | 6836篇 |
2015年 | 7569篇 |
2014年 | 10287篇 |
2013年 | 15445篇 |
2012年 | 20567篇 |
2011年 | 21545篇 |
2010年 | 12765篇 |
2009年 | 11973篇 |
2008年 | 20054篇 |
2007年 | 21582篇 |
2006年 | 21956篇 |
2005年 | 20486篇 |
2004年 | 20042篇 |
2003年 | 18982篇 |
2002年 | 18496篇 |
2001年 | 36360篇 |
2000年 | 36926篇 |
1999年 | 30411篇 |
1998年 | 7884篇 |
1997年 | 6669篇 |
1996年 | 6979篇 |
1995年 | 6632篇 |
1994年 | 6114篇 |
1993年 | 5597篇 |
1992年 | 23000篇 |
1991年 | 22949篇 |
1990年 | 22336篇 |
1989年 | 22097篇 |
1988年 | 20050篇 |
1987年 | 19438篇 |
1986年 | 18482篇 |
1985年 | 17325篇 |
1984年 | 12706篇 |
1983年 | 10748篇 |
1982年 | 5932篇 |
1979年 | 11525篇 |
1978年 | 8133篇 |
1977年 | 6838篇 |
1976年 | 6602篇 |
1975年 | 7271篇 |
1974年 | 8510篇 |
1973年 | 8145篇 |
1972年 | 7659篇 |
1971年 | 7135篇 |
1970年 | 6881篇 |
1969年 | 6315篇 |
1968年 | 5788篇 |
排序方式: 共有10000条查询结果,搜索用时 13 毫秒
141.
M K Song W Y Shin N F Adham N V Costea 《The American journal of clinical nutrition》1989,49(4):701-707
The effects of different amounts of dietary zinc on the Zn absorption rate and on Zn, calcium and magnesium concentrations in tissues of MOPC 104E tumor-bearing Balb/c mice were determined. The Zn absorption rate was inversely related to the amounts of Zn in their diets and was lower than that of nontumor-bearing control mice fed a laboratory mice chow. Zn concentrations of tumor-bearing mice were also low compared with control mice but tumor Zn concentrations, regardless of the concentrations of Zn in the diets, were higher than those of normal tissues of the host other than the pancreas. Ca concentrations in tumor and tissues of tumor-bearing mice were higher than in control animals but Mg concentrations in tissues of tumor-bearing mice appeared to be similar to those of control mice. Results suggest that tumor-bearing mice have a lower intestinal Zn absorption capacity and a higher Zn uptake rate causing other tissues to become hypozincemic and hypercalcemic. 相似文献
142.
A long-term clinical and therapeutic study was performed in 47 patients with mesangial IgA glomerulonephritis. The male to
female ratio was 2.9∶1. An episode of gross haematuria or the incidental discovery of asymptomatic microscopic haematuria
with associated mild proteinuria heralded the apparent onset of renal disease. At the onset of observation 18 patients (38.2%)
had high blood pressure. Other 17 patients developed hypertension during observation. Anaemia was uncommon. No essential abnormalities
in serum protein and lipid patterns were found. Twenty-nine patients (61.6%) had higher levels of serum immunoglobulins—most
frequently of IgA (42.5%). Twenty-two patients had low serum C3 levels (46.8%). The percentage of patients with renal failure increased from 21.2 to 36.1 during observation. Male sex, hypertension,
proteinuria higher than 2 g/24 h, elevated ESR, high serum IgA levels, longer duration of the disease and older age of patients
suggest an unfavourable outcome. Long-term treatment with a combination of azathioprine/acenocumarol, or indomethacin, or
levamisole has no effect on the clinical manifestation and evolution. 相似文献
143.
144.
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
Bayard L. Powell Hyman B. Muss Robert L. Capizzi Mary E. Caponera Douglas R. White Patricia J. Zekan James N. Atkins Don V. Jackson Jr. Frederick Richards II John B. Craig Julia M. Cruz Charles L. Spurr 《Cancer chemotherapy and pharmacology》1987,19(3):250-252
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182 相似文献
145.
4-Aminopyridine affects synaptosomal protein phosphorylation in rat hippocampal slices 总被引:2,自引:0,他引:2
Rat brain hippocampal slices were incubated with or without the convulsant 4-aminopyridine (4-AP). From these slices a crude mitochondrial/synaptosomal membrane fraction was prepared and analyzed for endogenous protein phosphorylation. 4-AP (10(-5) M) stimulated the phosphorylation of a 50 kDa protein by 86%. The phosphorylation of this 50 kDa protein is Ca2+/calmodulin-dependent and we suggest that this protein is the lower molecular weight subunit of Ca2+/calmodulin-dependent protein kinase II (CaMK II). 相似文献
146.
147.
148.
The authors have presented the results of a 14-day open randomized trial of the efficacy of 3 calcium inlet blocking agents: nifedipine, verapamil and phendilin in 61 patients with Raynaud's syndrome. In the group of patients receiving 30-80 mg of nifedipine (20) there was a significant decrease in the frequency and expression of Raynaud's syndrome attacks, a positive effect of varying degree was noted in 19 patients. The drug raised slightly the skin and muscular blood flow and skin temperature. The use of 120-360 mg of verapamil in 21 patients caused no significant inhibition of Raynaud's syndrome and rise of hemocirculation. Phendilin (150-300 mg) though being comparable with nifedipine in efficacy, often produced side-effects resulting in the drug cancellation (8 out of 20). The efficacy of the calcium inlet blocking agents, especially nifedipine, for therapy of Raynaud's syndrome was emphasized. 相似文献
149.
150.